<code id='AF0EF7001E'></code><style id='AF0EF7001E'></style>
    • <acronym id='AF0EF7001E'></acronym>
      <center id='AF0EF7001E'><center id='AF0EF7001E'><tfoot id='AF0EF7001E'></tfoot></center><abbr id='AF0EF7001E'><dir id='AF0EF7001E'><tfoot id='AF0EF7001E'></tfoot><noframes id='AF0EF7001E'>

    • <optgroup id='AF0EF7001E'><strike id='AF0EF7001E'><sup id='AF0EF7001E'></sup></strike><code id='AF0EF7001E'></code></optgroup>
        1. <b id='AF0EF7001E'><label id='AF0EF7001E'><select id='AF0EF7001E'><dt id='AF0EF7001E'><span id='AF0EF7001E'></span></dt></select></label></b><u id='AF0EF7001E'></u>
          <i id='AF0EF7001E'><strike id='AF0EF7001E'><tt id='AF0EF7001E'><pre id='AF0EF7001E'></pre></tt></strike></i>

          hotspot

          hotspot

          author:knowledge    Page View:9866
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          NIH nominee Bertagnolli will get October confirmation hearing
          NIH nominee Bertagnolli will get October confirmation hearing

          Dr.MonicaBertagnollispeaksduringavisitfromfirstladyJillBidentotheUniversityofCaliforniaSanFranciscoH

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Advances in CAR

          AdamFeuerstein,upperleft,moderatedapanelwith,clockwise,DavidChangofAllogeneTherapeutics,RachelHaurwi